Proton beam therapy for retroperitoneal neuroblastoma

Reporter: J. Taylor Whaley, MD
The Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 12 de mayo del 2011

Translation for this article does not exist


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

ASTRO: Combination Therapy Beneficial in Prostate Cancer

Nov 28, 2015

Twelve-year survival increased in medium-risk patients who receive add-on hormone therapy

Fewer Complications With IMRT for Prostate Cancer

Apr 18, 2012

Fewer gastro morbidities, hip fractures, but more erectile dysfunction versus conformal radiation

Topotecan Induction Feasible for High-Risk Neuroblastoma

Oct 19, 2011

No deaths or dose-limiting toxicities with dose-intensive topotecan, cyclophosphamide induction